Core Scientific Options Trading: A Deep Dive into Market Sentiment

We gleaned this information from our observations today when Benzinga's options scanner highlighted 10 extraordinary options activities for Core Scientific. This level of activity is out of the ordinary.

The general mood among these heavyweight investors is divided, with 40% leaning bullish and 60% bearish. Among these notable options, 8 are puts, totaling $335,625, and 2 are calls, amounting to $531,044.

What's The Price Target?

After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $7.5 and $10.0 for Core Scientific, spanning the last three months.

Volume & Open Interest Trends

Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Core Scientific's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Core Scientific's whale trades within a strike price range from $7.5 to $10.0 in the last 30 days.

Core Scientific Call and Put Volume: 30-Day Overview

Biggest Options Spotted:

About Core Scientific

In light of the recent options history for Core Scientific, it's now appropriate to focus on the company itself. We aim to explore its current performance.

Where Is Core Scientific Standing Right Now?

  • Trading volume stands at 3,859,592, with CORZ's price down by -1.55%, positioned at $9.55.
  • RSI indicators show the stock to be is currently neutral between overbought and oversold.
  • Earnings announcement expected in 93 days.

Professional Analyst Ratings for Core Scientific

In the last month, 3 experts released ratings on this stock with an average target price of $17.666666666666668.

  • Showing optimism, an analyst from B. Riley Securities upgrades its rating to Buy with a revised price target of $13.
  • An analyst from Cantor Fitzgerald has revised its rating downward to Overweight, adjusting the price target to $20.
  • An analyst from Cantor Fitzgerald has revised its rating downward to Overweight, adjusting the price target to $20.

Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.

If you want to stay updated on the latest options trades for Core Scientific, Benzinga Pro gives you real-time options trades alerts.

Market News and Data brought to you by Benzinga APIs

To add Benzinga News as your preferred source on Google, click here.